These results suggest that the repeat sequence of ABL1-MS1 suppresses the expression of ABL1. On the other hand, in the bladder cancer cell line UC3, inhibition of the ABL1 promoter activity by the repeat sequence was not seen (Fig. 4b). Here, ABL1 is linked to urinary bladder carcinoma.